PARAMETRIC PORTFOLIO ASSOCIATES LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q1 2022$3,243,000
-56.9%
50,770
-27.7%
0.00%
-50.0%
Q4 2021$7,522,000
+18.9%
70,229
+14.2%
0.00%0.0%
Q3 2021$6,324,000
+22.9%
61,509
+5.2%
0.00%
+33.3%
Q2 2021$5,144,000
-18.6%
58,484
-10.0%
0.00%
-25.0%
Q1 2021$6,318,000
-29.7%
64,975
-18.9%
0.00%
-33.3%
Q4 2020$8,984,000
+68.8%
80,105
+39.5%
0.01%
+50.0%
Q3 2020$5,322,000
+22.0%
57,416
+2.6%
0.00%
+33.3%
Q2 2020$4,364,000
+39.4%
55,952
+4.5%
0.00%0.0%
Q1 2020$3,131,000
-20.4%
53,548
+9.0%
0.00%0.0%
Q4 2019$3,935,000
+14.4%
49,115
+4.9%
0.00%0.0%
Q3 2019$3,439,000
+41.0%
46,802
+81.0%
0.00%
+50.0%
Q2 2019$2,439,000
+78.7%
25,853
+51.6%
0.00%
+100.0%
Q1 2019$1,365,000
+29.4%
17,054
-12.8%
0.00%0.0%
Q4 2018$1,055,000
-62.3%
19,563
-45.4%
0.00%
-50.0%
Q3 2018$2,795,000
+74.5%
35,806
+41.9%
0.00%0.0%
Q2 2018$1,602,000
-30.7%
25,236
+0.1%
0.00%0.0%
Q1 2018$2,312,000
+39.4%
25,218
+14.7%
0.00%0.0%
Q4 2017$1,658,000
+68.3%
21,981
+55.5%
0.00%
+100.0%
Q3 2017$985,000
+51.3%
14,137
+10.1%
0.00%0.0%
Q2 2017$651,000
+73.6%
12,838
+36.8%
0.00%0.0%
Q1 2017$375,0009,3840.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders